Latest AnalizaDx Inc. Stories
Novel assay found to be more accurate than traditional screening A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer. The study which will be...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.